These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34254132)

  • 21. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.
    Jog K; Nazirudeen R; Eagappan S; Santharam RK; Sridhar S
    Indian J Endocrinol Metab; 2023; 27(6):519-523. PubMed ID: 38371190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The baneful alliance of COVID-19 and mucormycosis: Histopathological concerns.
    Singh A; Kumar V; Kumar V; Verma N
    Indian J Pathol Microbiol; 2023; 66(1):106-110. PubMed ID: 36656220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
    Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
    Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucor in a Viral Land: A Tale of Two Pathogens.
    Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
    Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping.
    Hussain S; Baxi H; Riad A; Klugarová J; Pokorná A; Slezáková S; Líčeník R; Najmi AK; Klugar M
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study.
    Gandhi A; Narula A; Chandra S; Agarwal D; Mehta A; Nayak S; Arora S; Capoor MR
    Int Ophthalmol; 2023 May; 43(5):1571-1580. PubMed ID: 36273362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.
    Rudrabhatla PK; Reghukumar A; Thomas SV
    Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India.
    Choksi T; Agrawal A; Date P; Rathod D; Gharat A; Ingole A; Chaudhari B; Pawar N
    JAMA Ophthalmol; 2022 Jan; 140(1):66-72. PubMed ID: 34882192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
    Mani S; Thirunavukkarasu A
    Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for Coronavirus disease-associated mucormycosis.
    Arora U; Priyadarshi M; Katiyar V; Soneja M; Garg P; Gupta I; Bharadiya V; Berry P; Ghosh T; Patel L; Sarda R; Garg S; Agarwal S; Arora V; Ramprasad A; Kumar A; Garg RK; Kodan P; Nischal N; Singh G; Jorwal P; Kumar A; Baitha U; Meena VP; Ray A; Sethi P; Xess I; Vikram N; Sinha S; Biswas A; Thakar A; Bhatnagar S; Trikha A; Wig N
    J Infect; 2022 Mar; 84(3):383-390. PubMed ID: 34974056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: A single-center study of 270 patients from North India.
    Hada M; Gupta P; Bagarhatta M; Tripathy K; Harsh A; Khilnani K; Mendiratta K; Agarwal S; Chouhan JK; Bhandari S
    Indian J Ophthalmol; 2022 Feb; 70(2):641-648. PubMed ID: 35086254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
    Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
    Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.